Report signs of serious bleeding: black tarry stools, hematuria, hematemesis, or sudden severe headache.
Before you read
Test yourself first: 5 questions
Question 1 of 5
A client taking clopidogrel is also prescribed omeprazole for reflux. Why should the nurse question this combination with the provider?
Answer: A. Omeprazole inhibits the CYP2C19 enzyme needed to convert clopidogrel into its active form, reducing its antiplatelet effectiveness and increasing the risk of thrombotic events such as stent thrombosis. The interaction reduces, rather than enhances, clopidogrel's effect and is not related to absorption being increased.
Question 2 of 5
A client is prescribed clopidogrel after a transient ischemic attack (TIA). The nurse should teach the client to report which finding?
Answer: A. Clopidogrel is an antiplatelet agent that increases bleeding risk. The client should report signs of bleeding such as unusual bruising, blood in the stool or urine, or bleeding that does not stop. It does not require routine INR monitoring like warfarin, is taken to prevent another stroke (not to relieve headache), and is not stopped abruptly without provider direction.
Question 3 of 5
A client is prescribed clopidogrel after coronary stent placement. The nurse explains that the primary purpose of this medication is to:
Answer: B. Clopidogrel is an antiplatelet agent that inhibits platelet aggregation by blocking the P2Y12 ADP receptor, preventing thrombus formation on the stent. It does not dissolve existing clots (that is thrombolytics), lower cholesterol (statins), or directly inactivate clotting factors (anticoagulants).
Question 4 of 5
A client is prescribed clopidogrel after a coronary stent placement. Which statement by the client indicates a need for further teaching?
Answer: B. Clopidogrel is an antiplatelet drug that prevents stent thrombosis. Abruptly stopping it without provider guidance dramatically increases the risk of stent thrombosis, myocardial infarction, and death, so the statement about stopping it once feeling better indicates a need for further teaching. Reporting unusual bleeding, taking it with food for GI upset, and not stopping it before procedures without checking are correct understandings.
Question 5 of 5
A client with an ischemic stroke who is not a candidate for thrombolytics is prescribed clopidogrel. What is the primary purpose of this medication?
Answer: B. Clopidogrel is an antiplatelet agent that inhibits platelet aggregation, reducing the risk of recurrent ischemic stroke by preventing new clot formation.
Keep the streak going with more questions like these, each with a full rationale.
What is clopidogrel?
It is used after coronary stent placement, acute coronary syndrome, and ischemic stroke or peripheral arterial disease, often combined with aspirin as dual antiplatelet therapy. Its main risk is bleeding.
Key points to remember
- Irreversibly blocks the platelet P2Y12 receptor, so its effect lasts the lifespan of affected platelets (7-10 days).
- Frequently prescribed with aspirin as dual antiplatelet therapy after stenting.
- Bleeding is the principal adverse effect; combine cautiously with anticoagulants or NSAIDs.
- Proton pump inhibitors omeprazole and esomeprazole reduce its activation and effectiveness.
- Should be stopped about 5-7 days before elective surgery when ordered, but never discontinued after a stent without provider direction.
- It is a prodrug requiring CYP2C19 activation, so poor metabolizers may have reduced response.
Nursing priorities
- Assess for bleeding: bruising, petechiae, blood in stool or urine, and gum bleeding.
- Reinforce that the patient must not stop the drug abruptly after stent placement to avoid stent thrombosis.
- Review the medication list for NSAIDs, anticoagulants, and interacting PPIs.
- Hold doses as ordered before invasive procedures and coordinate with the surgical team.
Patient teaching
- Use a soft toothbrush and electric razor and avoid activities with high injury risk to reduce bleeding.
- Report black stools, blood in urine, or bleeding that does not stop with pressure.
- Do not stop taking this medication without talking to your provider, especially after a stent.
- Tell all providers and dentists you take an antiplatelet before any procedure.
- Avoid over-the-counter NSAIDs and certain heartburn drugs unless approved.
Red flags: report now
- Report signs of serious bleeding: black tarry stools, hematuria, hematemesis, or sudden severe headache.
- Stopping the drug after a coronary stent without provider approval can cause fatal stent thrombosis.
- Report any unusual or prolonged bleeding before procedures or dental work.
References
Clinical references for this topic
